We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Another Key Gene Discovered for Alzheimer’s Disease

By LabMedica International staff writers
Posted on 05 Oct 2017
The consensus among scientists has been that the Apolipoprotein E (ApoE4) gene is the main marker of Alzheimer's disease and many other dementias, but a new study has added another key player into the mix.

The ApoE gene is instrumental in forming lipoproteins, which are molecules that carry cholesterol and other fats through our bloodstream. More...
ApoE has several slightly different versions, and one of them, called e4, has been strongly associated with the risk of developing Alzheimer's disease. Moreover, the ApoE4 gene is linked to the buildup of amyloid plaque, which is a clumpy protein found in the brain tissue of Alzheimer's patients.

A group of international scientists led by those at the University of Southern California (Los Angeles, CA, USA) interviewed participants once every two years between 1996 and 2012, and another group did so between 2002 and 2012. For the test of immediate recall, the participants were read a list of 10 nouns and were asked to say them back to the interviewer immediately. But for the delayed recall test, the interviewer waited five minutes before asking participants to repeat the list.

The team adjusted the data for age and sex also examined the genetic data from 7,486 American participants and 6,898 European participants. In 2006, the first wave was collected from buccal swabs using the Qiagen Autopure method. In 2008, the second wave was collected using Oragene saliva kits and extraction method. Both waves were genotyped using the HumanOmni2.5-4v1 array.

Overall, the scientists examined 1.2 million genetic variations in the human genome, looking for associations between these gene variations and the results of the memory tests. Only the Translocase of Outer Mitochondrial Membrane 40 (TOMM40) gene was found to be strongly associated with a decline in immediate and delayed recall. The results also showed an association with the "traditional" genetic culprit, ApoE4, but the link was not as strong. Additionally, the analysis revealed that the e3 variant of the ApoE gene was also associated with a low memory score, when found in conjunction with the TOMM40 gene.

Carol A. Prescott, PhD, a professor of Psychology and senior author of the study said, “Our findings indicate that TOMM40 plays a larger role, specifically, in the decline of verbal learning after age 60. Other studies may not have detected the effects of TOMM40. The results from this study provide more evidence that the causes of memory decline are even more complicated than we thought before, and they raise the question of how many findings in other studies have been attributed to ApoE4 that may be due to TOMM40 or a combination of TOMM40 and ApoE4.” The study was published on August 11, 2017, in the journal Public Library of Science ONE.

Related Links:
University of Southern California


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.